DUBLIN--(BUSINESS WIRE)--The "Nerve Repair and Regeneration Market - Growth, Trends, and Forecasts (2020 - 2025)" report has been added to ResearchAndMarkets.com's offering.
The Nerve Repair and Regeneration Market are expected to register a CAGR of 12.2% during the forecast period.
The market is expected to show growth due to the growing incidence of nerve injuries and high prevalence of neurological disorders, technological advancements for nerve repair and regeneration and the rise in healthcare expenditure by the government with favourable policies in the developed market.
The increase in neurological diseases is found to be the major contributors to the global burden of disease. There are over 1,000 disorders of the nervous system, including cerebrovascular disease, Alzheimer's disease, and other dementias, migraine, epilepsy, tetanus, meningitis, Parkinson's disease, multiple sclerosis, and poliomyelitis, that are among the other major diseases.
Key Market Trends
Stem Cell Therapy in the Application Segment is Expected to Witness the Fastest CAGR Over the Forecast Period
Stem cell therapy segment is expected to witness the fastest CAGR due to the various government initiatives and approvals to conduct clinical trials of biomaterials. According to the Organisation for Economic Co-operation and Development (OECD), in 2018, the average per capita healthcare expenditure in Denmark was around USD 5,300.
Furthermore, as per the Alzheimer Europe 2019 report, estimates that the number of people with dementia in Italy in 2018 was around 1,279,366 and this number is projected to double to around 2,247,715 in 2050. Similarly, as a percentage of the overall population with dementia will represent 4.13% in 2050 compared to 2.12% in 2018. As a number of people will dementia is expected to double in the near future which is expected to boost the market.
A high number of research centres, universities, and companies, from European nations, the United States, and Canada, are also conducting several clinical trials for the application of stem cell-based therapies in nerve repair and regeneration. These countries are found to be backed by high government funding, well-developed healthcare infrastructure, and widespread global presence. Hence, owing to above factors the segment is expected to show growth market over the forecast period.
North America is Expected to Hold a Significant Share in the Market
North America is expected to dominate the market owing to increasing incidence of neurological disorders and supportive health insurance coverage scenario in the region. There is also the availability of technologically advanced devices that is a major factor for the dominance of this region. For instance, according to the Alzheimer's Association, number of Americans living with Alzheimer's is growing and growing fast. More than 5 million Americans of all ages had Alzheimer's in 2019. An estimated 5.8 million Americans age 65 and older are living with Alzheimer's dementia in 2020. 80% of population are age 75 or older. 1 in 10 people above 65 years of age (10%) has Alzheimer's dementia. Almost two-thirds of Americans with Alzheimer's are women.
Key Topics Covered:
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Growing Incidence of Nerve Injuries and High Prevalence of Neurological Disorders
4.2.2 Technological Advancements for Nerve Repair and Regeneration
4.2.3 Rise in Healthcare Expenditure by Government with Favorable Policies in Developed Market
4.3 Market Restraints
4.3.1 High Cost Associated with the Devices
4.3.2 Dearth of Trained Professionals
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Product Type
5.1.1 Neurostimulation and Neuromodulation Devices
184.108.40.206 Internal Neurostimulation Device
220.127.116.11.1 Spinal Cord Stimulation (SCS)
18.104.22.168.2 Deep Brain Stimulation (DBS)
22.214.171.124.3 Vagus Nerve Stimulation (VNS)
126.96.36.199.4 Sacral Nerve Stimulation (SNS)
188.8.131.52.5 Gastric Electrical Stimulation (GES)
184.108.40.206 External Neurostimulation Device
220.127.116.11.1 Transcutaneous Electrical Nerve Stimulation (TENS)
18.104.22.168.2 Transcranial Magnetic Stimulation (TMS)
22.214.171.124 Nerve Conduit
126.96.36.199 Nerve Protector
188.8.131.52 Nerve Connector
184.108.40.206 Other Biomaterials
5.2 By Application
5.2.1 Neurostimulation and Neuromodulation Surgeries
5.2.2 Direct Nerve Repair / Neurorrhaphy
5.2.3 Nerve Grafting
5.2.4 Stem Cell Therapy
5.2.5 Other Applications
5.3.1 North America
5.3.4 Middle-East and Africa
5.3.5 South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Abbott Laboratories
6.1.2 Axogen Corporation
6.1.4 Boston Scientific Corporation
6.1.5 Integra LifeSciences Corporation
6.1.8 NeuroPace Inc.
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
For more information about this report visit https://www.researchandmarkets.com/r/t7fs6y